Trial Profile
A Mechanistic Study in Patients With Non-Dialysis Chronic Kidney Disease to Investigate Altered Platelet Response to Antiplatelet Therapy (CKD-Platelet Study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Mar 2023
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Ticagrelor (Primary) ; Clopidogrel
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms CKD-Platelet
- 01 Feb 2023 Primary endpoint has been met, (ADP Induced Platelet Aggregation), as per Results published in the Vascular Pharmacology
- 01 Feb 2023 Results published in the Vascular Pharmacology
- 13 Sep 2021 Planned primary completion date changed from 30 Sep 2021 to 30 Sep 2022.